Comparison of efficacy of low vs high dose of Atorvastatin and Rosuvastatin in reducing 50% LDL in diabetic patient

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180929041169N1

Enrollment

100

Registered

2019-01-07

Start date

2018-09-23

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes melitus. Type 1 diabetes mellitus,Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Diabetic patients between 40 to 75years (no use of lower lipid drugs in past 2 months) divide to four groups.Each group contains 25 pateint. First Intervention grou

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Diabetic patient who need to receive Statin according to ADA 2018

Exclusion criteria

Exclusion criteria: Pregnancy Patients of Genetic Disease Use of other lowering agent other than Statin Hx of Angina Hx of Nephropathy Hx of Hypothyroidism Hx of liver Dx or ALT> 3 ULN,AST>3 ULN CPK> 10 ULN Patients on Corticosteroids Patients with Cyclosporins or Hormone replacement therapy Hx of use of alcohol

Design outcomes

Primary

Measure	Time frame
Measurment of levels of Low Density lipoprotein. Timepoint: At the initial and 2 month after medication used. Method of measurement: Method of Photometric.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Taghi Gorji

Iran University of Medical Sciences

dr.hgorji@yahoo.com+98 21 8603 6064

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026